A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

Tina Willits, now 53, thought she had just two years to live. Today, she is cancer-free — and she wants the world to know about the treatment that saved her.

This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...

From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the ...

MLB Hall of Famer Ryne Sandberg has revealed that his prostate cancer has returned and spread. The former Chicago Cubs star, ...

Prostate cancer treatment has never looked so promising for men. Here's what every man needs to ask their doctor today!

The firm presented early data for a blood-based approach to screen prostate cancer patients for PSMA, which it believes has ...

A recent study found that fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG PET/CT) was better ...

Cancer is considered metastatic when it has spread to distant lymph nodes ... it has been largely replaced by a combination of PET scans and endobronchial guided ultrasound biopsy, which can often be ...